Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povorcitinib Phase 2 in Hidradenitis Suppurativa
NCT04476043Phase 2Completed
- Sponsor
- Incyte
- Start
- Aug 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of povorcitinib in hidradenitis suppurativa (HS), sponsored by Incyte. Started Aug 2020; status: completed.
02
Drugs
povorcitinib
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT04476043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476043.